Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Cell Host & Microbe
|
March 4, 2021
B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies
Samantha M Townsley, Gina C Donofrio, Ningbo Jian, et al.
The Lancet. Infectious Diseases
|
June 30, 2023
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial
Michael A Koren, Leyi Lin, Kenneth H Eckels, et al.
Mbio
|
August 29, 2025
First-generation N-terminal domain supersite public antibodies retain activity against Omicron-derived lineages and protect mice against Omicron BA.5 challenge
Vincent Dussupt, Jaime L Jensen, Paul V Thomas, et al.
Annals of the New York Academy of Sciences
|
November 16, 2022
Antibodies as drugs-a Keystone Symposia report
Jennifer Cable, Erica Ollmann Saphire, Adrian C Hayday, et al.
Journal of Virology
|
May 15, 2015
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research
Lindsay Wieczorek, Shelly J Krebs, Vaniambadi Kalyanaraman, et al.
Journal of Virology
|
July 3, 2023
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
Jaime L Jensen, Rajeshwer S Sankhala, Vincent Dussupt, et al.
Iscience
|
October 1, 2024
SARS-CoV-2 ferritin nanoparticle vaccines produce hyperimmune equine sera with broad sarbecovirus activity
Elizabeth J Martinez, William C Chang, Wei-Hung Chen, et al.
Plos Pathogens
|
December 8, 2020
RV144 HIV-1 vaccination impacts post-infection antibody responses
Thembi Mdluli, Ningbo Jian, Bonnie Slike, et al.
Plos Pathogens
|
March 2, 2021
Correction: RV144 HIV-1 vaccination impacts post-infection antibody responses
Thembi Mdluli, Ningbo Jian, Bonnie Slike, et al.
Virus Evolution
|
September 17, 2021
RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection
Eric Lewitus, Eric Sanders-Buell, Meera Bose, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Cell Host & Microbe
|
March 4, 2021
B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies
Samantha M Townsley, Gina C Donofrio, Ningbo Jian, et al.
The Lancet. Infectious Diseases
|
June 30, 2023
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial
Michael A Koren, Leyi Lin, Kenneth H Eckels, et al.
Mbio
|
August 29, 2025
First-generation N-terminal domain supersite public antibodies retain activity against Omicron-derived lineages and protect mice against Omicron BA.5 challenge
Vincent Dussupt, Jaime L Jensen, Paul V Thomas, et al.
Annals of the New York Academy of Sciences
|
November 16, 2022
Antibodies as drugs-a Keystone Symposia report
Jennifer Cable, Erica Ollmann Saphire, Adrian C Hayday, et al.
Journal of Virology
|
May 15, 2015
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research
Lindsay Wieczorek, Shelly J Krebs, Vaniambadi Kalyanaraman, et al.
Journal of Virology
|
July 3, 2023
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
Jaime L Jensen, Rajeshwer S Sankhala, Vincent Dussupt, et al.
Iscience
|
October 1, 2024
SARS-CoV-2 ferritin nanoparticle vaccines produce hyperimmune equine sera with broad sarbecovirus activity
Elizabeth J Martinez, William C Chang, Wei-Hung Chen, et al.
Plos Pathogens
|
December 8, 2020
RV144 HIV-1 vaccination impacts post-infection antibody responses
Thembi Mdluli, Ningbo Jian, Bonnie Slike, et al.
Plos Pathogens
|
March 2, 2021
Correction: RV144 HIV-1 vaccination impacts post-infection antibody responses
Thembi Mdluli, Ningbo Jian, Bonnie Slike, et al.
Virus Evolution
|
September 17, 2021
RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection
Eric Lewitus, Eric Sanders-Buell, Meera Bose, et al.
Page
of 6